The first Vagus Nerve Stimulator (VNS) was implanted in 1988, as a therapeutic option for medically intractable epilepsy, when elective epilepsy surgery was not appropriate.
As the number of implanted vagus nerve stimulators grows, so does the need to remove or revise the devices.
Which is a little tricky, because of the spiral stimulating electrodes, wrapped around the nerve.
Especially if the VNS treatment has proven ineffective.
And of course, what goes in, must come out.
Anyway you look at it, there’s more surgery involved.
Posted in
Epilepsy,
Medication Issues,
News,
ResearchTags:
alternative,
better seizure control,
depression reduction,
drug-resistant,
effective,
enhancement,
Epilepsy,
no side-effects,
no surgery,
non-invasive,
post traumatic stress,
success rate,
trigeminal nerve stimulation,
vagus nerve stimulator
It’s only recently that Neuroengineering first appeared.
Neuroengineering is a discipline at the frontier between neuroscience and engineering.
It encompasses experimental, computational, theoretical, clinical and applied aspects of research areas at the molecular, cellular and systems levels.
The emergence of this new field focuses on a multi-science combination of engineers, neuroscientists and clinicians using their combined knowledge and talent, working co-operatively to address the complexity of the brain and nervous system.
Posted in
Epilepsy,
Medication Issues,
News,
ResearchTags:
AEDS,
brain,
clinicians,
engineers,
enhancement,
Epilepsy,
human health,
multi-science,
Neuroengineering,
neuroscientists,
quality of life,
restoration,
seizure-free,
surgery,
underlying seizures